Back to Search
AGNES STOCH, DO
DO
Family Medicine Physician
NPI: 1497192983IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryFAMILY PRACTICE
Education
MIDWESTERN UNIVERSITY, CHICAGO COLLEGE OF OSTEOPATHIC MED
Class of 2013
Research & Publications (6)
The value, qualification, and regulatory use of surrogate end points in drug development.
PMID 19474783·Clin Pharmacol Ther·2009
6-review
The influence of SiO2 and SiO2-TiO2 intermediate coatings on bond strength of titanium and Ti6Al4V alloy to dental porcelain.
PMID 19395017·Dent Mater·2009
8-other
Influence of taranabant, a cannabinoid-1 receptor inverse agonist, on pharmacokinetics and pharmacodynamics of warfarin.
PMID 18989636·Adv Ther·2008
3-trial
Multiple-dose pharmacokinetics, pharmacodynamics, and safety of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, in healthy male volunteers.
PMID 18508950·J Clin Pharmacol·2008
2-rct
Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, for the treatment of obesity: results from a double-blind, placebo-controlled, single oral dose study in healthy volunteers.
PMID 18258750·J Clin Pharmacol·2008
2-rct
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake.
PMID 18177726·Cell Metab·2008
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2285 SEQUOIA DR
AURORA, IL 60506 - Phone
- (630) 859-6859
Quick Facts
- NPI
- 1497192983
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 13
- Publications
- 6
Are you this provider?
Claim Your Profile